Old West Investment Management LLC acquired a new stake in shares of Cabot Corporation (NYSE:CBT - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,326 shares of the specialty chemicals company's stock, valued at approximately $1,119,000.

• 10 Best Natural Gas Stocks to Buy Now

A number of other institutional investors and hedge funds also recently made changes to their positions in CBT. NewEdge Advisors LLC increased its position in Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company's stock valued at $82,000 after buying an additional 947 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company's stock worth $36,802,000 after acquiring an additional 108,645 shares in the last quarter. Empowered Funds LLC boosted its holdings in Cabot by 102.6% in the first quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company's stock worth $2,341,000 after acquiring an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Cabot by 3.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company's stock valued at $10,145,000 after acquiring an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. grew its stake in Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after acquiring an additional 364 shares during the period. Institutional investors own 93.18% of the company's stock.

Insider Activity

In other news, CEO Sean D. Keohane sold 91,923 shares of the stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the sale, the chief executive officer owned 404,134 shares in the company, valued at $34,921,218.94. This represents a 18.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.08% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

• Cabot Boosting Production In Lithium Battery Chain For EV Market

CBT has been the topic of a number of recent research reports. Mizuho increased their target price on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a report on Thursday, June 25th. Truist Financial set a $100.00 price target on shares of Cabot in a research note on Wednesday, August 5th. Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a report on Tuesday, May 26th. Wall Street Zen raised shares of Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Finally, UBS Group decreased their target price on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $89.00.

Get Our Latest Analysis on CBT

Cabot Stock Down 0.1%

CBT stock opened at $87.82 on Monday. The firm has a market capitalization of $4.53 billion, a PE ratio of 24.74, a P/E/G ratio of 11.47 and a beta of 0.84. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The stock's 50 day moving average is $88.12 and its 200-day moving average is $80.46.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to the consensus estimate of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot's revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts expect that Cabot Corporation will post 6.33 EPS for the current fiscal year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. Cabot's dividend payout ratio is presently 53.24%.

Cabot Company Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Read More

• Five stocks we like better than Cabot
• The Metals Company’s Big Bet Now Comes Down to a License
• OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
• Meta and Tesla Are Rebounding From Oversold Levels—Now What?
• AMG’s Alternatives Boom Powers Record Growth

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here